Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

– Acquisition Funded by Collegium's Cash on Hand and New Five-Year Financing with Significantly Improved Terms – STOUGHTON, Mass. and GEORGE TOWN, Cayman Islands, July 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) and Ironshore Therapeutics Inc. today announced a definitive agreement pursuant to which Collegium will acquire Ironshore for $525 million in cash with the potential for an additional $25 million commercial milestone payment. Transaction Rationale Under the terms of th ...